Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
SEPN · against 395 other Healthcare companies of similar size
Ranked #309 of 396 · scores higher than 22% of peers
Bars: peers in each 10-point band of the profitability score29 peers with a profitability score of 20–29, including SEPN · Click a bar to see the companies
Mainly because of its operating margin, return on invested capital and return on assets, which are weaker than most Healthcare peers.
| Metric | SEPN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 373 reported | -11.4% | 5.9% | 22% | 33% | |
| Operating marginHigher is better · 367 reported | -44.0% | 8.0% | 14% | 33% | |
| Return on assetsHigher is better · 378 reported | -4.3% | 2.0% | 27% | 33% | |
| Return on equityHigher is better · 364 reported | -6.3% | 5.0% | 31% | Context only | |
| Gross marginHigher is better · 410 reported | 100.0% | 49.1% | 97% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 5 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 306 | 9.1B CNY (≈$1.3B) | 26 | 20 | |
| 306 | 12.1B CNY (≈$1.7B) | 26 | 15 | |
| 306 | 3.3B USD | 26 | 44 | |
| 309 | 1.9B USD | 25 | 44 | |
| 309 | 2.0B USD | 25 | 53 | |
| 311 | 12.7B CNY (≈$1.8B) | 24 | 20 | |
| 311 | 1.5B USD | 24 | 44 | |
| 311 | 2.0B USD | 24 | 42 | |
| 314 | 14.2B CNY (≈$2.0B) | 23 | 10 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score